The Role of the CT-Scan in Diagnosis and Follow-Up in Patients with Metastatic Testicular Cancer

Author(s):  
K. Scheiber ◽  
D. Zur Nedden ◽  
G. Jakse
2019 ◽  
Vol 18 (7) ◽  
pp. e2832
Author(s):  
A. Rivero Cardenes ◽  
J.M. Hernandez ◽  
J. Montero Torres ◽  
J. Díaz Romero ◽  
E. Gutierrez Mínguez
Keyword(s):  

2007 ◽  
Vol 25 (9) ◽  
pp. 1024-1025 ◽  
Author(s):  
Lawrence H. Einhorn

1979 ◽  
Vol 72 (11) ◽  
pp. 818-822 ◽  
Author(s):  
George Blackledge ◽  
Jonathan K Best ◽  
Derek Crowther

Twenty-six computed tomography (CT) examinations in 18patients with histologically proven gastrointestinal lymphomas are reported. Fourteen CT examinations were performed at the time of initial presentation, the others being performed during the course of the disease. CT did not help in the diagnosis of the disease but it is effective in assessing the extent and thus the stage of the disease. A normal CT scan during follow up is associated with good prognosis. CT may be of help in planning treatment, especially radiotherapy. It is an investigation easily tolerated by patients and can be used in circumstances where other investigations would be impossible.


Author(s):  
Sara Naybandi Atashi ◽  
Zeinab Naderpour ◽  
Keyvan Goharimoghadam ◽  
Morteza Saeedi

In recent months, coronavirus disease 2019 (COVID-19) is a significant global health problem that has a tremendous negative impact on the human being, and almost all countries of the world have been affected by the disease. CT imaging techniques have an important role in the primary diagnosis of pneumonia secondary to COVID-19; moreover, the level of pulmonary involvement in CT scan is one of the criteria for disease severity in the acute phase of COVID-19 pneumonia. Still, the role of CT scan in the follow-up period is unknown.


2017 ◽  
Vol 35 (15_suppl) ◽  
pp. e16043-e16043
Author(s):  
Shahid Sattar Ahmed ◽  
Joseph Jacob ◽  
Clint Cary ◽  
Richard Foster ◽  
Lawrence H. Einhorn

e16043 Background: Management of metastatic testicular cancer often requires post-chemotherapy resection of teratoma. This is well known and described in literature. However, the ability of teratoma to metastasize independently is not as well appreciated, making chemotherapy futile in patients with pure metastatic teratoma. Methods: 15 patients with metastatic teratoma were identified of which 13 had only teratoma in the orchiectomy and 2 had predominantly teratoma. All 15 had normal serum hCG and AFP. Cases were derived from a retrospective review of patients seen from 1989-2016. Results: Mean age of patients was 27 years. 12 patients presented initially with Stage II disease and 2 presented with stage III disease. Median RP mass size was 6 cm with a range of 1.5-24 cm. 2 of 15 patients were treated initially with a single course of chemotherapy with BEP and showed no response. The remaining 13 patients only received resection(s). All 15 patients underwent RPLND with 2 patients requiring additional mediastinal and retrocrural resection and 1 requiring lobectomy. All surgical specimens showed pure teratoma on pathology with no other active germ cells. Patients were followed for a median duration of 5 years and all 15 remain with no evidence of disease at most recent follow up. However, 1 patient needed subsequent surgery for a late relapse of teratoma and 1 patient had a second extra-gonadal primary. Conclusions: Teratoma can metastasize in the absence of other germ cells. Surgical treatment alone for patients with pure metastatic teratoma of any stage can result in cure for the majority of patients and this approach can help avoid unnecessary chemotherapy.


2015 ◽  
Vol 2015 ◽  
pp. 1-4
Author(s):  
Kelly T. Harris ◽  
Shakil A. Shaikh ◽  
Mark W. Ball ◽  
Mohamad E. Allaf ◽  
Phillip M. Pierorazio

We present a patient with a metachronous, second testicular cancer after being diagnosed with pre-B cell ALL and receiving induction chemotherapy for a bone marrow transplant. We discuss the management of bilateral testis masses in a young patient with a hematologic malignancy as well as the role of immunosuppressive chemotherapy in developing a second cancer. This case illustrates the importance of recognizing bilateral testicular cancer early, as well as the importance of follow-up care in oncology patients including routine measurements of tumor markers. A multidisciplinary approach between medical oncology and urology, including close monitoring of the contralateral testis, remains paramount to patient care.


2021 ◽  
Vol 2021 ◽  
pp. 1-8
Author(s):  
Antonio Orlacchio ◽  
Silvia Roma ◽  
Vito dell’Olio ◽  
Sara Crociati ◽  
Ilaria Lenci ◽  
...  

Purpose. To assess the ability of Cone-Beam CT (CBCT), performed during the Transcatheter Arterial Chemoembolization (TACE), in predicting the response to treatment of hepatocellular carcinoma (HCC). Materials and Methods. We evaluated fifty patients (M/F = 40/10, mean age: 66.7 years ± 8.22) with hepatocellular carcinoma (HCC), for a total of 82 nodules evaluated (mean diameter: 21.4 ± 11 mm). All patients performed a CT scan one month before and one month after TACE. After TACE is completed, a CBCT was performed to assess the degree of drug retention in the lesions. For each lesion, the major diameter, volume, and density of the vital portion were evaluated. The response to TACE was assessed using the mRECIST criteria on the CT scan carried out one month after the procedure. The receiver operating characteristic (ROC) curves were performed to assess the accuracy of the CBCT in predicting the response to treatment and to identify the cut-off points for each parameter under examination. Results. A complete response (CR) was observed in 24/50 patients (48%), a partial response (PR) in 16/50 (32%), stable disease (SD) in 8/50 (16%), and progressive disease (PD) in 2/50 (4%). Evaluation of the area under the ROC curve showed that the diameter, volume, and density of the lesion, measured with CBTC, had an accuracy of 94%, 96%, and 98%, respectively, in discriminating a complete response from a not complete response. Conclusion. CBCT is effective in predicting short-term response at 1-month follow-up of HCC treated by chemoembolization.


2017 ◽  
Vol 16 (2) ◽  
pp. 51-56
Author(s):  
Nuray Voyvoda ◽  
Bekir Voyvoda ◽  
Özden Çamurdan

Sign in / Sign up

Export Citation Format

Share Document